Global Metachromatic Leukodystrophy (MLD) Treatment Market Report By Type (AGT-183, DUOC-01, GSK-2696274, Others), By Application (Hospital, Clinic, Others), And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2020-2027

ID:VMR11212390
April 2021
Report Formats:
The global demand for Metachromatic Leukodystrophy (MLD) Treatment Market is presumed to reach the valuation of nearly USD XX MN by 2026 from USD XX MN in 2019 with a CAGR of XX% under the study period of 2020 - 2026.
 
Metachromatic Leukodystrophy is a genetic disorder caused by a lack of an important enzyme in the blood called Arylsulfatase-A. It affects the white matter, or myelin, of the brain and the central nervous system. There are three types of MLD: late-infantile MLD, juvenile MLD, and adult MLD. Currently, there is no cure for MLD but symptoms can be well-managed. Bone marrow or cord blood transplantation has been found effective treating MLD. Many therapeutics are under reaserch among which gene therapy is one of promising one.
 
Market Dynamics
 
Metachromatic Leukodystrophy is a rare disease reported to occur in one in 40,000 to 160,000 people worldwide. The prevalence is greater in certain genetically isolated populations. Rise in awareness about diseases in developed as well as developing regions is likely to fuel the growth of global metachromatic leukodystrophy treatment market The therapeutic options available for treating MLD is limited but is predicted to expand with a number of early stages of clinical trials in progress. Since MLD is caused by defective ASA, most therapeutic approaches are focussed on correcting the biochemical defect by providing wild-type ASA. Gene therapy is one of the promising therapeutic for MLD. But during therapeutic research, the scientist has been facing many challenges that include blood-brain barrier (BBB) penetration, uncertainty regarding the ideal timing for intervention in the disease course, safety issues concerning therapies targeting the central nervous system, and the lack of more in-depth understanding of the molecular pathogenesis of MLD.
 
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
 
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of metachromatic leukodystrophy (mld) treatment.
 
Market Segmentation
 
The entire metachromatic leukodystrophy (mld) treatment market has been sub-categorized into type and application. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
 
By Type
  • AGT-183
  • DUOC-01
  • GSK-2696274
  • Others
 
By Application
  • Hospital
  • Clinic
  • Others
 
Regional Analysis
 
This section covers regional segmentation which accentuates on current and future demand for metachromatic leukodystrophy (mld) treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
 
Global Metachromatic Leukodystrophy (MLD) Treatment Market Share by Region (Representative Graph)
 
Global Metachromatic Leukodystrophy (MLD) Treatment Market Share
 
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the metachromatic leukodystrophy (mld) treatment market include ArmaGen Inc., GlaxoSmithKline Plc, Recursion Pharmaceuticals Inc., RegenxBio Inc., Shire Plcs. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
                                            
METHODOLOGY:
 
This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources,  Technical Journals, Financial Reports, SEC Filings, and other different industry publications.
 
If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Metachromatic Leukodystrophy (Mld) Treatment Market
       2.2. Global Metachromatic Leukodystrophy (Mld) Treatment Market Snapshot
 
3 . METACHROMATIC LEUKODYSTROPHY (MLD) TREATMENT – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Metachromatic Leukodystrophy (Mld) Treatment Market
       3.3. Market Restraints of Metachromatic Leukodystrophy (Mld) Treatment Market
       3.4. Opportunities of Metachromatic Leukodystrophy (Mld) Treatment Market
       3.5. Trends of Metachromatic Leukodystrophy (Mld) Treatment Market
       3.6. Porter’s Five Force Analysis of Metachromatic Leukodystrophy (Mld) Treatment Market
       3.7. Metachromatic Leukodystrophy (Mld) Treatment Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Type
           3.7.2 Market Attractive Analysis by Application
           3.7.3 Market Attractive Analysis by Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Metachromatic Leukodystrophy (Mld) Treatment Value Chain Analysis
       4.2. Metachromatic Leukodystrophy (Mld) Treatment Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Metachromatic Leukodystrophy (Mld) Treatment Raw Material Manufactures List
           4.2.3. Price Trend of Metachromatic Leukodystrophy (Mld) Treatment Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak on Metachromatic Leukodystrophy (Mld) Treatment Market
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Metachromatic Leukodystrophy (Mld) Treatment Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Metachromatic Leukodystrophy (Mld) Treatment Market Size in 2020, by Scenario
       5.5. COVID-19: Micro and Macro Factor Analysis on Metachromatic Leukodystrophy (Mld) Treatment Market
 
6 . GLOBAL METACHROMATIC LEUKODYSTROPHY (MLD) TREATMENT MARKET ANALYSIS BY TYPE
       6.1 Overview by Type
       6.2 Global Metachromatic Leukodystrophy (Mld) Treatment Market Analysis by Type
       6.3 Market Analysis of AGT-183 by Regions
       6.4 Market Analysis of DUOC-01 by Regions
       6.6 Market Analysis of GSK-2696274 by Regions
       6.5 Market Analysis of Others by Regions
 
7 . GLOBAL METACHROMATIC LEUKODYSTROPHY (MLD) TREATMENT MARKET ANALYSIS BY APPLICATION
       7.1 Overview by Application
       7.2 Global Metachromatic Leukodystrophy (Mld) Treatment Market Analysis by Application
       7.3 Market Analysis of Hospital by Regions
       7.4 Market Analysis of Clinic by Regions
       7.5 Market Analysis of Others by Regions
 
8 . GLOBAL METACHROMATIC LEUKODYSTROPHY (MLD) TREATMENT MARKET ANALYSIS BY GEOGRAPHY
       8.1. Regional Outlook
       8.2. Introduction
       8.3. North America
           8.3.1. Overview
           8.3.2. North America Metachromatic Leukodystrophy (Mld) Treatment Market Estimate by Market Segment
           8.3.3. North America Metachromatic Leukodystrophy (Mld) Treatment Market Estimate by Country
           8.3.4. United State
           8.3.5. Rest of North America
       8.4. Europe
           8.4.1. Overview
           8.4.2. Europe Metachromatic Leukodystrophy (Mld) Treatment Market Estimate by Market Segment
           8.4.3. Europe Metachromatic Leukodystrophy (Mld) Treatment Market Estimate by Country
           8.4.4. United Kingdom
           8.4.5. France
           8.4.6. Germany
           8.4.8 Rest of Europe
       8.5. Asia Pacific
           8.5.1. Overview
           8.5.2. Asia Pacific Metachromatic Leukodystrophy (Mld) Treatment Market Estimate by Market Segment
           8.5.3. Asia Pacific Metachromatic Leukodystrophy (Mld) Treatment Market Estimate by Country
           8.5.4. China
           8.5.5. Japan
           8.5.6. India
           8.5.8. Rest of Asia Pacific
       8.6. Latin America
           8.6.1. Overview
           8.6.2. Latin America Metachromatic Leukodystrophy (Mld) Treatment Market Estimate by Market Segment
           8.6.3. Latin America Metachromatic Leukodystrophy (Mld) Treatment Market Estimate by Country
           8.6.4. Brazil
           8.6.5. Rest of Latin America
       8.8. Middle East & Africa
           8.8.1. Overview
           8.8.2. Middle East & Africa Metachromatic Leukodystrophy (Mld) Treatment Market Estimate by Market Segment
           8.8.3. Middle East & Africa Metachromatic Leukodystrophy (Mld) Treatment Market Estimate by Country
           8.8.4. Middle East
           8.8.5. Africa
 
9 . COMPETITIVE LANDSCAPE OF THE METACHROMATIC LEUKODYSTROPHY (MLD) TREATMENT COMPANIES
       9.1. Metachromatic Leukodystrophy (Mld) Treatment Market Competition
       9.2. Partnership/Collaboration/Agreement
       9.3. Merger And Acquisitions
       9.4. New Product Launch
       9.5. Other Developments
 
10 . COMPANY PROFILES OF METACHROMATIC LEUKODYSTROPHY (MLD) TREATMENT INDUSTRY
       10.1. Company Share Analysis
       10.2. Market Concentration Rate
       10.3. ArmaGen Inc.
           10.3.1. Company Overview
           10.3.2. Financials
           10.3.3. Products
           10.3.4. Recent Developments
       10.4. GlaxoSmithKline Plc
           10.4.1. Company Overview
           10.4.2. Financials
           10.4.3. Products
           10.4.4. Recent Developments
       10.5. Recursion Pharmaceuticals Inc.
           10.5.1. Company Overview
           10.5.2. Financials
           10.5.3. Products
           10.5.4. Recent Developments
       10.6. RegenxBio Inc.
           10.6.1. Company Overview
           10.6.2. Financials
           10.6.3. Products
           10.6.4. Recent Developments
       10.7. Shire Plcs
           10.7.1. Company Overview
           10.7.2. Financials
           10.7.3. Products
           10.7.4. Recent Developments
 
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
LIST OF TABLES

  • Global Metachromatic Leukodystrophy (Mld) Treatment Market Snapshot
  • Drivers of The Global Metachromatic Leukodystrophy (Mld) Treatment Market Impact Analysis
  • Restraints of The Global Metachromatic Leukodystrophy (Mld) Treatment Market Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Metachromatic Leukodystrophy (Mld) Treatment Market: Pre V/S Post COVID-19
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic On The Metachromatic Leukodystrophy (Mld) Treatment Market Size In 2020, By Scenario
  • COVID-19: Micro and Macro Factor Analysis on Metachromatic Leukodystrophy (Mld) Treatment Market
  • Global Metachromatic Leukodystrophy (Mld) Treatment Market Analysis by Type (USD MN)
  • Global Metachromatic Leukodystrophy (Mld) Treatment Market Analysis in AGT-183 by Geography (USD MN)
  • Global Metachromatic Leukodystrophy (Mld) Treatment Market Analysis in DUOC-01 by Geography (USD MN)
  • Global Metachromatic Leukodystrophy (Mld) Treatment Market Analysis in GSK-2696274 by Geography (USD MN)
  • Global Metachromatic Leukodystrophy (Mld) Treatment Market Analysis in Others by Geography (USD MN)
  • Global Metachromatic Leukodystrophy (Mld) Treatment Market Analysis by Application (USD MN)
  • Global Metachromatic Leukodystrophy (Mld) Treatment Market Analysis in Hospital by Geography (USD MN)
  • Global Metachromatic Leukodystrophy (Mld) Treatment Market Analysis in Clinic by Geography (USD MN)
  • Global Metachromatic Leukodystrophy (Mld) Treatment Market Analysis in Others by Geography (USD MN)
  • Global Metachromatic Leukodystrophy (Mld) Treatment Market by Geography (USD MN)
  • North America Metachromatic Leukodystrophy (Mld) Treatment Market Analysis by Type (USD MN)
  • North America Metachromatic Leukodystrophy (Mld) Treatment Market Estimate by Application (USD MN)
  • North America Metachromatic Leukodystrophy (Mld) Treatment Market Estimate by Country (USD MN)
  • United State Metachromatic Leukodystrophy (Mld) Treatment Market Analysis by Type (USD MN)
  • United State Metachromatic Leukodystrophy (Mld) Treatment Market Estimate by Application (USD MN)
  • Rest of North America Metachromatic Leukodystrophy (Mld) Treatment Market Analysis by Type (USD MN)
  • Rest of North America Metachromatic Leukodystrophy (Mld) Treatment Market Estimate by Application (USD MN)
  • Europe Metachromatic Leukodystrophy (Mld) Treatment Market Analysis by Type (USD MN)
  • Europe Metachromatic Leukodystrophy (Mld) Treatment Market Estimate by Application (USD MN)
  • United Kingdom Metachromatic Leukodystrophy (Mld) Treatment Market Analysis by Type (USD MN)
  • United Kingdom Metachromatic Leukodystrophy (Mld) Treatment Market Estimate by Application (USD MN)
  • France Metachromatic Leukodystrophy (Mld) Treatment Market Analysis by Type (USD MN)
  • France Metachromatic Leukodystrophy (Mld) Treatment Market Estimate by Application (USD MN)
  • Germany Metachromatic Leukodystrophy (Mld) Treatment Market Analysis by Type (USD MN)
  • Germany Metachromatic Leukodystrophy (Mld) Treatment Market Estimate by Application (USD MN)
  • Rest of Europe Metachromatic Leukodystrophy (Mld) Treatment Market Analysis by Type (USD MN)
  • Rest of Europe Metachromatic Leukodystrophy (Mld) Treatment Market Estimate by Application (USD MN)
  • Asia Pacific Metachromatic Leukodystrophy (Mld) Treatment Market Analysis by Type (USD MN)
  • Asia Pacific Metachromatic Leukodystrophy (Mld) Treatment Market Estimate by Application (USD MN)
  • Asia Pacific Metachromatic Leukodystrophy (Mld) Treatment Market Estimate by Country (USD MN)
  • China Metachromatic Leukodystrophy (Mld) Treatment Market Analysis by Type (USD MN)
  • China Metachromatic Leukodystrophy (Mld) Treatment Market Estimate by Application (USD MN)
  • Japan Metachromatic Leukodystrophy (Mld) Treatment Market Analysis by Type (USD MN)
  • Japan Metachromatic Leukodystrophy (Mld) Treatment Market Estimate by Application (USD MN)
  • India Metachromatic Leukodystrophy (Mld) Treatment Market Analysis by Type (USD MN)
  • India Metachromatic Leukodystrophy (Mld) Treatment Market Estimate by Application (USD MN)
  • Rest of Asia Pacific Metachromatic Leukodystrophy (Mld) Treatment Market Analysis by Type (USD MN)
  • Rest of Asia Pacific Metachromatic Leukodystrophy (Mld) Treatment Market Estimate by Application (USD MN)
  • Latin America Metachromatic Leukodystrophy (Mld) Treatment Market Analysis by Type (USD MN)
  • Latin America Metachromatic Leukodystrophy (Mld) Treatment Market Estimate by Application (USD MN)
  • Latin America Metachromatic Leukodystrophy (Mld) Treatment Market Estimate by Country (USD MN)
  • Brazil Metachromatic Leukodystrophy (Mld) Treatment Market Analysis by Type (USD MN)
  • Brazil Metachromatic Leukodystrophy (Mld) Treatment Market Estimate by Application (USD MN)
  • Rest of Latin America Metachromatic Leukodystrophy (Mld) Treatment Market Analysis by Type (USD MN)
  • Rest of Latin America Metachromatic Leukodystrophy (Mld) Treatment Market Estimate by Application (USD MN)
  • Middle East & Africa Metachromatic Leukodystrophy (Mld) Treatment Market Analysis by Type (USD MN)
  • Middle East & Africa Metachromatic Leukodystrophy (Mld) Treatment Market Estimate by Application (USD MN)
  • Middle East & Africa Metachromatic Leukodystrophy (Mld) Treatment Market Estimate by Country (USD MN)
  • Middle East Metachromatic Leukodystrophy (Mld) Treatment Market Analysis by Type (USD MN)
  • Middle East Metachromatic Leukodystrophy (Mld) Treatment Market Estimate by Application (USD MN)
  • Africa Metachromatic Leukodystrophy (Mld) Treatment Market Analysis by Type (USD MN)
  • Africa Metachromatic Leukodystrophy (Mld) Treatment Market Estimate by Application (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton
  • New Product Launch
  • Other Developments
  • Company Market Share Analysis, 2019
 
LIST OF FIGURES
 
  • Research Scope of Metachromatic Leukodystrophy (Mld) Treatment Report
  • Market Research Process
  • Market Research Methodology
  • Global Metachromatic Leukodystrophy (Mld) Treatment Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Type
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Metachromatic Leukodystrophy (Mld) Treatment Market Analysis by Type (USD MN)
  • Global Metachromatic Leukodystrophy (Mld) Treatment Market Analysis in AGT-183 by Geography (USD MN)
  • Global Metachromatic Leukodystrophy (Mld) Treatment Market Analysis in DUOC-01 by Geography (USD MN)
  • Global Metachromatic Leukodystrophy (Mld) Treatment Market Analysis in GSK-2696274 by Geography (USD MN)
  • Global Metachromatic Leukodystrophy (Mld) Treatment Market Analysis in Others by Geography (USD MN)
  • Global Metachromatic Leukodystrophy (Mld) Treatment Market Analysis by Application (USD MN)
  • Global Metachromatic Leukodystrophy (Mld) Treatment Market Analysis in Hospital by Geography (USD MN)
  • Global Metachromatic Leukodystrophy (Mld) Treatment Market Analysis in Clinic by Geography (USD MN)
  • Global Metachromatic Leukodystrophy (Mld) Treatment Market Analysis in Others by Geography (USD MN)
  • Latin America Metachromatic Leukodystrophy (Mld) Treatment Market by Revenue
  • Middle East & Africa Metachromatic Leukodystrophy (Mld) Treatment Market by Revenue
  • Recent Development in Metachromatic Leukodystrophy (Mld) Treatment Industry
  • Company Market Share Analysis, 2019
 
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials